Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bioline RX Gets European Device Confirmation for Bl-5010 Drug

Sept. 15 (Bloomberg) -- Bioline RX Ltd. said it received European confirmation for the classification of its BL-5010 drug to treat seborrheic keratosis skin lesions, as a medical device Class IIa, according to a statement filed today with the Tel Aviv Stock Exchange.

Link to Company News:{BLRX IT <Equity> CN <GO>}

To contact the reporter on this story: Sharon Wrobel in Tel Aviv at

To contact the editor responsible for this story: Calev Ben-David at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.